Literature DB >> 26518209

Different activations of toll-like receptors and antimicrobial peptides in chronic rhinosinusitis with or without nasal polyposis.

Andor Hirschberg1, Maria Kiss2, Edit Kadocsa3, Hilda Polyanka4, Kornelia Szabo4, Zsolt Razga5, Zsolt Bella3, Laszlo Tiszlavicz5, Lajos Kemeny2,4.   

Abstract

Both up- and down-regulation of the Toll-like receptors (TLRs) and antimicrobial peptides (AMPs) of the sinonasal mucosa have already been associated with the pathogenesis of chronic rhinosinusitis with (CRSwNP) or without (CRSsNP) nasal polyps. The objective of this study was to determine the expression of all known TLR and several AMP genes and some selected proteins in association with allergy, asthma and aspirin intolerance (ASA) in CRS subgroups. RT-PCR was applied to measure the mRNA expressions of 10 TLRs, four defensins, lysozyme, cathelicidin and lactoferrin (LTF) in sinonasal samples from patients with CRSsNP (n = 19), CRSwNP [ASA(-): 17; ASA(+): 7] and in control subjects (n = 12). Protein expressions were detected with immunohistochemistry (n = 10). Statistical analysis was done with the Kruskal-Wallis ANOVA, Mann-Whitney U, and Student t test. TLR2, TLR5, TLR6, TLR7, TLR8, TLR9, β-defensins 1 and 4, cathelicidin and LTF mRNA expressions were significantly (p < 0.05) increased in CRSwNP, whereas only TLR2 and LTF were up-regulated in CRSsNP compared to controls. There was no statistical difference in respect of allergy, aspirin intolerance and smoking between CRSsNP, ASA(-) and ASA(+) CRSwNP patients. TLR2, TLR3, TLR4, LTF, β defensin 2 and lysozyme protein expressions were found to be elevated in macrophages of CRSwNP samples (p < 0.05). Gene expression analysis showed markedly different expressions in CRSwNP (6 out of 10 TLR and 4 out of 7 AMP genes were up-regulated) compared to CRSsNP (1/10, 1/7). The distinct activation of the innate immunity may support the concept that CRSsNP and CRSwNP are different subtypes of CRS. These findings were found to be independent from allergy, asthma, smoking, aspirin intolerance and systemic steroid application.

Entities:  

Keywords:  Antimicrobial peptide; Chronic rhinosinusitis; Nasal polyp; Toll-like receptor

Mesh:

Substances:

Year:  2015        PMID: 26518209     DOI: 10.1007/s00405-015-3816-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  34 in total

1.  Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway.

Authors:  Zhen Dong; Zhanquan Yang; Chengshuo Wang
Journal:  Am J Rhinol       Date:  2005 May-Jun

2.  Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis.

Authors:  Nicole A Abreu; Nabeetha A Nagalingam; Yuanlin Song; Frederick C Roediger; Steven D Pletcher; Andrew N Goldberg; Susan V Lynch
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

3.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

Authors:  Wytske J Fokkens; Valerie J Lund; Joachim Mullol; Claus Bachert; Isam Alobid; Fuad Baroody; Noam Cohen; Anders Cervin; Richard Douglas; Philippe Gevaert; Christos Georgalas; Herman Goossens; Richard Harvey; Peter Hellings; Claire Hopkins; Nick Jones; Guy Joos; Livije Kalogjera; Bob Kern; Marek Kowalski; David Price; Herbert Riechelmann; Rodney Schlosser; Brent Senior; Mike Thomas; Elina Toskala; Richard Voegels; De Yun Wang; Peter John Wormald
Journal:  Rhinology       Date:  2012-03       Impact factor: 3.681

4.  Antimicrobial defensin peptides of the human nasal mucosa.

Authors:  Sang Hag Lee; Jung Eun Kim; Hyun Ho Lim; Heung Man Lee; Jong Ouck Choi
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-02       Impact factor: 1.547

5.  Antifungal immune reactivity in nasal polyposis.

Authors:  Lucia Pitzurra; Silvia Bellocchio; Angela Nocentini; Pierluigi Bonifazi; Raffaele Scardazza; Luigi Gallucci; Fabrizio Stracci; Costantino Simoncelli; Francesco Bistoni; Luigina Romani
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 6.  Perspectives on the etiology of chronic rhinosinusitis.

Authors:  Bruce K Tan; Robert P Schleimer; Robert C Kern
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-02       Impact factor: 2.064

7.  Differential expression of Toll-like receptor pathway genes in chronic rhinosinusitis with or without nasal polyps.

Authors:  Qi Zhang; Cheng-Shuo Wang; De-Min Han; Christopher Sy; Qian Huang; Yan Sun; Er-Zhong Fan; Ying Li; Bing Zhou
Journal:  Acta Otolaryngol       Date:  2012-11-19       Impact factor: 1.494

8.  Expression of human beta-defensin 2 in human nasal mucosa.

Authors:  Po-Hsu Chen; Sheen-Yie Fang
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-09-18       Impact factor: 2.503

9.  Reduced levels of lactoferrin in biofilm-associated chronic rhinosinusitis.

Authors:  Alkis J Psaltis; Peter-John Wormald; Kien R Ha; Lor Wai Tan
Journal:  Laryngoscope       Date:  2008-05       Impact factor: 3.325

10.  Sinonasal epithelial cell expression of Toll-like receptor 9 is elevated in cystic fibrosis-associated chronic rhinosinusitis.

Authors:  Thuy-Anh N Melvin; Andrew P Lane; Mai-Tien Nguyen; Sandra Y Lin
Journal:  Am J Rhinol Allergy       Date:  2013-01       Impact factor: 2.467

View more
  11 in total

Review 1.  Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Whitney W Stevens; Robert P Schleimer; Robert C Kern
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jul-Aug

2.  Bacteriological analysis of selected phenotypes of chronic rhinosinusitis with co-existing asthma, allergy and hypersensitivity to non-steroidal anti-inflammatory drugs.

Authors:  Grażyna Stryjewska-Makuch; Małgorzata A Janik; Hanna Klamińska-Cebula; Bogdan Kolebacz; Wojciech Ścierski; Grażyna Lisowska
Journal:  Postepy Dermatol Alergol       Date:  2021-03-10       Impact factor: 1.837

3.  Staphylococcus aureus Overcomes Anaerobe-Derived Short-Chain Fatty Acid Stress via FadX and the CodY Regulon.

Authors:  Joshua R Fletcher; Alex R Villareal; Mitchell R Penningroth; Ryan C Hunter
Journal:  J Bacteriol       Date:  2022-04-07       Impact factor: 3.476

Review 4.  Mechanisms and pathogenesis of chronic rhinosinusitis.

Authors:  Atsushi Kato; Robert P Schleimer; Benjamin S Bleier
Journal:  J Allergy Clin Immunol       Date:  2022-03-01       Impact factor: 14.290

5.  Polyphenolic Profile, Anti-Inflammatory and Anti-Nociceptive Activities of Some African Medicinal Plants.

Authors:  Windmi Kagambega; Hadidjatou Belem; Roland Nâg-Tiéro Meda; Benjamin Kouliga Koama; Anne-Flora Drabo; Jacques Kabore; Amadou Traore; Georges Anicet Ouédraogo; Daniela Benedec; Daniela Hanganu; Laurian Vlase; Ana-Maria Vlase; Oliviu Voștinaru; Cristina Mogoșan; Ilioara Oniga
Journal:  Plants (Basel)       Date:  2022-05-22

Review 6.  Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.

Authors:  Robert P Schleimer
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

Review 7.  Differential expression and role of S100 proteins in chronic rhinosinusitis.

Authors:  Jorgen S Sumsion; Abigail Pulsipher; Jeremiah A Alt
Journal:  Curr Opin Allergy Clin Immunol       Date:  2020-02

Review 8.  The microbiome of the upper respiratory tract in health and disease.

Authors:  Christina Kumpitsch; Kaisa Koskinen; Veronika Schöpf; Christine Moissl-Eichinger
Journal:  BMC Biol       Date:  2019-11-07       Impact factor: 7.431

Review 9.  TLR Signals in Epithelial Cells in the Nasal Cavity and Paranasal Sinuses.

Authors:  Masanobu Suzuki; Clare Cooksley; Takayoshi Suzuki; Mahnaz Ramezanpour; Akira Nakazono; Yuji Nakamaru; Akihiro Homma; Sarah Vreugde
Journal:  Front Allergy       Date:  2021-11-22

10.  Inflammatory Endotypes and Microbial Associations in Chronic Rhinosinusitis.

Authors:  Michael Hoggard; Sharon Waldvogel-Thurlow; Melissa Zoing; Kevin Chang; Fiona J Radcliff; Brett Wagner Mackenzie; Kristi Biswas; Richard G Douglas; Michael W Taylor
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.